492 related articles for article (PubMed ID: 33002736)
1. β-lactam antibiotics: An overview from a medicinal chemistry perspective.
Lima LM; Silva BNMD; Barbosa G; Barreiro EJ
Eur J Med Chem; 2020 Dec; 208():112829. PubMed ID: 33002736
[TBL] [Abstract][Full Text] [Related]
2. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
3. Redefining penems.
Dalhoff A; Janjic N; Echols R
Biochem Pharmacol; 2006 Mar; 71(7):1085-95. PubMed ID: 16413506
[TBL] [Abstract][Full Text] [Related]
4. β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
González-Bello C; Rodríguez D; Pernas M; Rodríguez Á; Colchón E
J Med Chem; 2020 Mar; 63(5):1859-1881. PubMed ID: 31663735
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
6. Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors.
Gehlot P; P H
Environ Pollut; 2022 Dec; 314():120289. PubMed ID: 36180000
[TBL] [Abstract][Full Text] [Related]
7. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
Liu B; Trout REL; Chu GH; McGarry D; Jackson RW; Hamrick JC; Daigle DM; Cusick SM; Pozzi C; De Luca F; Benvenuti M; Mangani S; Docquier JD; Weiss WJ; Pevear DC; Xerri L; Burns CJ
J Med Chem; 2020 Mar; 63(6):2789-2801. PubMed ID: 31765155
[TBL] [Abstract][Full Text] [Related]
9. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
Lucic A; Hinchliffe P; Malla TR; Tooke CL; Brem J; Calvopiña K; Lohans CT; Rabe P; McDonough MA; Armistead T; Orville AM; Spencer J; Schofield CJ
Eur J Med Chem; 2021 Apr; 215():113257. PubMed ID: 33618159
[TBL] [Abstract][Full Text] [Related]
10. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
11. An Extensive Review on β-lactamase Enzymes and their Inhibitors.
Agarwal V; Tiwari A; Varadwaj P
Curr Med Chem; 2023; 30(7):783-808. PubMed ID: 35726414
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
13. Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.
Bebrone C; Lassaux P; Vercheval L; Sohier JS; Jehaes A; Sauvage E; Galleni M
Drugs; 2010 Apr; 70(6):651-79. PubMed ID: 20394454
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics.
Egorov AM; Ulyashova MM; Rubtsova MY
Biochemistry (Mosc); 2020 Nov; 85(11):1292-1309. PubMed ID: 33280574
[TBL] [Abstract][Full Text] [Related]
15. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
Buynak JD
Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
[TBL] [Abstract][Full Text] [Related]
16. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
Palacios AR; Rossi MA; Mahler GS; Vila AJ
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
[TBL] [Abstract][Full Text] [Related]
17. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
18. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
[TBL] [Abstract][Full Text] [Related]
19. Three decades of beta-lactamase inhibitors.
Drawz SM; Bonomo RA
Clin Microbiol Rev; 2010 Jan; 23(1):160-201. PubMed ID: 20065329
[TBL] [Abstract][Full Text] [Related]
20. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance.
Kang SJ; Kim DH; Lee BJ
Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
